课题基金 / 基金详情

An investigation of DNA repair processes during DNA replication using the archaeon, Sulfolobus, as a model organism.

An investigation of DNA repair processes during DNA replication using the archaeon, Sulfolobus, as a model organism.
使用古细菌 Sulfolobus 作为模式生物,研究 DNA 复制过程中的 DNA 修复过程。
批准号:
G0701443/1
负责人:
Nicholas Robinson
金额:
$119.08万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mutations in DNA are responsible for a number of medical diseases including cancers. The aim of this study is further our understanding of how cells prevent and repair DNA damage during DNA replication, the process when DNA is copied prior to cell division. The intricacy of the mechanisms involved in human and animal cells can complicate direct experimental observation, and for this reason we often use ‘simple‘ model organisms to gain further insight into these processes. In this study, I intend to examine new aspects of DNA repair using a single-celled model organism that thrives in harsh environmental conditions at temperatures of up to 80 C. This organism, called Sulfolobus, belongs to an ancient superfamily of microorganisms called archaea that are genetically distinct from bacteria. In fact, the archaeal apparatus for DNA replication and repair is more closely related to the machineries found in animal cells rather than those present in bacteria. Sulfolobus is also easy and inexpensive to cultivate, and the robustness of the heat-stable proteins isolated from these organisms facilitates experimental investigation. Therefore, Sulfolobus is an ideal organism in which to study the basic processes of replication-associated DNA repair.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
解码精母细胞特异5’UTR元件调控DNA损伤修复基因MSH5翻译挽救减数分裂障碍的研究
  • 批准号:
    82371607
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    李铮
  • 依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
PHF19上调EXD2促进DNA损伤修复增加胶质瘤放疗抵抗的作用与机制研究
  • 批准号:
    32100591
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    何江
  • 依托单位:
STRIPAK复合物调控DNA损伤修复及肠癌化疗耐药的功能与机制研究
  • 批准号:
    32070710
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    安利伟
  • 依托单位: